We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




GE Gets Final Approvals for Instrumentarium Acquisition

By HospiMedica staff writers
Posted on 03 Oct 2003
The remaining regulatory approvals required for its acquisition of Instrumentarium Corp. (Helsinki, Finland) have been received by GE Medical Systems (Waukesha, WI, USA), according to a GE announcement.

These approvals include those of the US Department of Justice and the Canadian Competition Bureau. The European Commission had previously announced approval. GE's tender offer for all Instrumentarium shares and options is set to expire on September 30, 2003. In order to address issues raised by regulators, GE has agreed to divest the Ziehm surgical C-arm business of Instrumentarium. The company has also reconfirmed its agreement with the European Commission to divest the Spacelabs patient monitoring business and to maintain on a global basis the current practice of GE and Instrumentarium of open interfaces for the products covered by the commitments.

GE states that it will announce the results of the company's tender offer on or about October 6, 2003. If the minimum acceptance level is met, tendering shareholders and option holders will receive payment of the offer price on or about October 14, 2003.





Related Links:
Instrumentarium
GE Medical Systems
Medical Radiographic X-Ray Machine
TR30N HF
Multi-Use Ultrasound Table
Clinton
Adjustable Mobile Barrier
M-458
Ultrasound Needle Guidance System
SonoSite L25

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.